Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-99,890
Closed -$3.77M 1321
2019
Q1
$3.77M Sell
99,890
-29,760
-23% -$1.11M 0.01% 715
2018
Q4
$4.71M Hold
129,650
0.02% 620
2018
Q3
$4.45M Hold
129,650
0.02% 705
2018
Q2
$4.18M Buy
129,650
+21,550
+20% +$744K 0.02% 692
2018
Q1
$3.12M Buy
+108,100
New +$2.85M 0.01% 760

Other funds holding IFRX

Axa's IFRX Position: Q2 2019 in Review

Axa sold out of InflaRx (IFRX) in Q2 2019, closing a stake of 99,890 shares — an estimated $3.77M sold.

Axa first reported a position in IFRX in Q1 2018 and held it in 5 quarters. The position peaked at $4.71M in Q4 2018. 28 funds tracked by Wall St. Rank hold IFRX as of Q2 2019.

  • Axa reported no remaining InflaRx position as of Q2 2019 after selling out during the quarter.
  • Axa sold 99,890 InflaRx shares in Q2 2019, an estimated $3.77M.
  • Axa first reported a position in InflaRx in Q1 2018 and held it in 5 quarters.
  • Axa's InflaRx position peaked at $4.71M in Q4 2018.
  • 28 funds tracked by Wall St. Rank held InflaRx as of Q2 2019.

Based on Axa's 13F filing for Q2 2019, filed 13 Aug 2019.